David Dornan
Chief Scientific Officer · Whitehawk Therapeutics, Inc.
Individual
- 2026
- Sep 18, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Dornan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David James Lennon - $1.06M in WHWK purchases and sales in the last 12 months
- Scott M. Giacobello - $891K in WHWK purchases and sales in the last 12 months
- Bryan Ball - $635K in WHWK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Dornan?
David Dornan is a corporate insider, tracked as Chief Scientific Officer of Whitehawk Therapeutics, Inc. (WHWK). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Dornan submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.